Phase 3 Vascularization Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 2Phase 3
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Age-Related Macular DegenerationMacular DegenerationChoroidal Neovascularization+1 more
EyeBiotech Ltd.960 enrolled30 locationsNCT07440225
Recruiting
Phase 2Phase 3
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Age-Related Macular DegenerationMacular DegenerationChoroidal Neovascularization+1 more
EyeBiotech Ltd.960 enrolled9 locationsNCT07496567
Recruiting
Phase 3
Improving Mobility After Revascularization in Peripheral Artery Disease
intermittent claudicationMobility LimitationPeripheral Artery Disease+2 more
Northwestern University386 enrolled7 locationsNCT06686121
Recruiting
Phase 2Phase 3
Corneal Crosslinking for Treatment of Corneal Neovascularization
Corneal Neovascularization
Price Vision Group62 enrolled1 locationNCT04787471
Recruiting
Phase 2Phase 3
Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin
Diabetic Macular EdemaMacular EdemaRetinal Neovascularization
Isfahan University of Medical Sciences52 enrolled1 locationNCT06595355
Completed
Phase 3Phase 4
Intravitreal dexamethasone for resistant wet-AMD
Wet aged macular degenerationResistent choroidal neovascularization
A.O.U. Sassari20 enrolled1 locationACTRN12618001102268
Completed
Phase 3
"The LoDoCo2 Trial":Low Dose Colchicine for secondary prevention of cardiovascular disease.
Ischemia-driven coronary revascularizationCardiovascular deathIschemic Stroke
Heart Research Institute, Sir Charles Gairdner Hospital5,500 enrolled1 locationACTRN12614000093684